Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citus Dry Syrup for Perennial Allergic Rhinitis in Children
NCT01539304Phase 3Completed
- Sponsor
- Sam-A Pharm
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Setopen in perennial allergic rhinitis (PAR), sponsored by Sam-A Pharm. Started Sep 2010; status: completed.
02
Drugs
Setopen
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01539304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539304.